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Abstract
In basic and applied HIV research, reliable detection of viral components is crucial to monitor progression of infection. While
it is routine to detect structural viral proteins in vitro for diagnostic purposes, it previously remained impossible to directly
and dynamically visualize HIV in living cells without genetic modification of the virus. Here, we describe a novel fluorescent
biosensor to dynamically trace HIV-1 morphogenesis in living cells. We generated a camelid single domain antibody that
specifically binds the HIV-1 capsid protein (CA) at subnanomolar affinity and fused it to fluorescent proteins. The resulting
fluorescent chromobody specifically recognizes the CA-harbouring HIV-1 Gag precursor protein in living cells and is
applicable in various advanced light microscopy systems. Confocal live cell microscopy and super-resolution microscopy
allowed detection and dynamic tracing of individual virion assemblies at the plasma membrane. The analysis of subcellular
binding kinetics showed cytoplasmic antigen recognition and incorporation into virion assembly sites. Finally, we
demonstrate the use of this new reporter in automated image analysis, providing a robust tool for cell-based HIV research.
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Introduction
Over the last decades, a large number of HIV (Human
Immunodeficiency Virus) detection methodologies have been
developed. Such techniques include in vitro based approaches to
measure primary infection in patients, for example by detecting
HIV-specific antibodies or by directly detecting HIV-derived,
structural proteins (e.g. the capsid protein CA/p24). Cell-based
HIV detection relies on molecular imaging techniques, such as
immunofluorescence, and electron microscopy, which both allow
direct visualization of viral structures but require cell fixation. Live
cell reporter systems include the implementation of genetic
reporter elements that get activated upon HIV infection [1,2,3]
as well as recombinant viruses, where tags or fluorescent proteins
have been integrated to study replication dynamics in living cells.
In particular, HIV assembly processes in living cells have been a
major subject of investigation over the last years (recently reviewed
[4,5]). HIV-1 virion assembly is orchestrated by the viral
polyprotein Gag. Gag consists of an N-terminal matrix domain
(MA) that mediates membrane attachment, an internal capsid
domain (CA) that mediates multimerization of Gag, a nucleocap-
sid domain (NC) that binds and packages the viral RNA genome
and a C-terminal p6 peptide that is involved in virus budding and
release. Upon virion budding, Gag gets proteolytically processed
by the viral protease and subdomains are released as functional
proteins within mature virions. In principle, genetically encoded
tags for live cell imaging purposes may be integrated at various
sites within the Gag polyprotein. For example, C-terminal
insertion of the green fluorescent protein (GFP) as well as internal
insertion at the C-terminus of the MA domain allows dynamic
visualization of the assembly of virus like particles (VLPs) [6,7,8].
The latter insertion site proved particularly compatible with viral
replication and has been used for different tagging strategies,
including biarsenical-tetracysteine tagging and SNAP-tagging
[9,10].
Having such tools at hands, various modern light microscopy
techniques, including widefield, confocal and total internal
reflection fluorescence microscopy, have been used to investigate
the HIV assembly process at both single-cell and single virion
level, elucidating the spatiotemporal dynamics of HIV morpho-
genesis and demonstrating molecular interactions with viral and
host factors [11,12,13,14]. Moreover, novel live-cell super-
resolution imaging techniques [15,16] will likely open new
possibilities to study fluorescently labeled viruses. However, all
these new imaging techniques rely on recombinant viral fusion
proteins while the direct visualization of genetically unmodified
HIV still remained elusive.
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The recent development of fluorescent intracellular single
domain nanobodies, so-called chromobodies [17,18,19], offers a
general approach for dynamic detection and visualization of
virtually any natural and genetically unmodified factor in living
cells.
Here, we describe a high affinity chromobody that allows direct
and dynamic visualization of HIV-1 formation in living cells.
Results
Generation of a CA-specific nanobody
In a first step to generate a nanobody reporter for HIV-1
detection in living cells, an alpaca was immunized with purified
HIV-1 CA protein and a phagemid library was generated,
representing the respective VHH (nanobody) repertoire. Three
subsequent phage display cycles revealed an enrichment of one
VHH sequence (Figure 1a). Antigen recognition and subdomain
specificity was tested in a solid phase phage-ELISA with purified
CA, the isolated N-terminal domain of CA (CANTD) and the
isolated C-terminal domain of CA (CACTD), indicating specific CA
binding and a binding preference for CANTD (Figure 1b). For
further binding analysis in vitro, the nanobody, termed CANTDcb1,
was cloned with a C-terminal 66His-tag, expressed in E. coli and
purified with immobilized metal ion affinity chromatography and
size-exclusion chromatography. To determine the binding affinity,
purified CANTDcb1 was tested in a continuous-flow Quartz
Crystal Microbalance (QCM) system. Affinity measurements with
full-length CA resulted in a KD value of 0,16 nM (Figure 1c),
which is comparable to binding affinities of conventional
antibodies [20]. Further binding measurements with isolated CA
domains confirmed specific binding to CANTD (Figure 1d).
CANTDcb1 colocalizes with HIV structures at the plasma
membrane
Next, we set out to develop live cell detection of HIV-1 and in
particular of the CA domain in the HIV-1 Gag polyprotein. For
this purpose, we genetically fused the coding region of the CA-
specific nanobody to fluorescent proteins, generating so-called
chromobodies [17]. Expression of these constructs in HeLa-Kyoto
cells showed ubiquitous, predominantly diffuse distribution,
indicating that they do not interact with cellular structures
(Figure 2a). To test intracellular binding of CANTDcb1 to viral
structures, HeLa-Kyoto cells were transfected with plasmids
encoding all HIV-1 proteins (except Nef), giving rise to HIV-1-
like particles with eGFP embedded in the MA domain of Gag
[7,8]. Cells were then co-transfected with constructs, carrying
either mCherry (Figure 2b) or CANTDcb1 coupled to mCherry
(Figure 2c). mCherry co-transfected cells showed discrete focal
structures of GFP-labelled Gag primarily at the plasma mem-
brane, likely corresponding to assembly sites with mCherry signal
being distributed throughout the cell. Importantly, CANTDcb1 co-
localized with viral assembly structures at the plasma membrane,
indicating specific binding, but no significant interference with
Gag membrane targeting in living cells.
CANTDcb1 directly detects individual HIV-1 assembly sites
Since CANTDcb1 colocalized with GFP-tagged viral structures,
we anticipated it to be well suited for visualizing even untagged
antigen in living cells. Thus, HeLa-Kyoto cells were co-transfected
with a non-infectious plasmid pcHIV, producing non-labelled
HIV particles, together with a plasmid encoding CANTDcb1
coupled to eGFP, and were then subjected to confocal light
microscopy. Co-expression resulted in specific localization of
CANTDcb1 to discrete focal structures at the plasma membrane
(Figure 3b), similar to the GFP-labelled HIV structures, strongly
indicating that CANTDcb1 allows direct visualization of HIV-1
Gag assemblies, Co-expression of CANTDcb1 did not abolish
particle release, indicating that its binding to Gag is compatible
with virion morphogenesis, while effects on infectivity cannot be
excluded.
Detailed analyses of these focal structures by conventional light
microscopy techniques are limited by diffraction and mediate
resolution of subcellular structures to max. 200 nm. As a
consequence, individual viruses with a size of about 100–
150 nm, such as HIV-1, cannot be resolved. The recent
development of super-resolution microscopy systems, including
3D-Structured Illumination Microscopy (3D-SIM) [21,22], over-
comes this analytical limitation. Thus, to further validate the
nature of HIV-1 structures, directly stained with CANTDcb1 in
living cells, we performed 3D-SIM on preserved formaldehyde-
fixed HeLa-Kyoto cells. For reasons of comparison, a conventional
widefield image was recorded, exhibiting signal enrichment at the
cellular periphery with strong out-of-focus blur (Figure 4 a). In
the 3D-SIM image, showing a cellular mid section, the membra-
Figure 1. Identification and in vitro characterization of a CA-specific nanobody. (A) Amino acid sequence of CANTDcb1. (B) CANTDcb1 was
tested for antigen specificity by solid phase phage ELISA, showing significant binding response for full-length CA and CANTD but no binding to CACTD.
Purified GFP was used as negative control. Bars show representative values of technical duplicates. (C) Affinity measurements with a quartz crystal
microbalance (QCM) system. Data fitting (red lines) and rate constant calculation was carried out with ClampXP analysis software. (D) To further
measure and confirm binding specificity, purified full-length CA, CANTD or CACTD were injected at 10 mg/ml and passed over immobilized CANTDnb1.
doi:10.1371/journal.pone.0050026.g001
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nous structures are resolved as individual punctae with low
background signal, suggesting the detection of individual viral
assembly sites (Figure 4 b, c). The projection of 120 cross sections
demonstrates the ubiquitous distribution of viral assemblies over
the entire cell surface (Figure 4 d). Intensity plot profiling over
representative punctae revealed a size range of about 130–160 nm
for these structures, strongly indicating that CANTDcb1 is
Figure 2. Intracellular antigen recognition. (A) mCherry-labelled CANTDcb1, expressed in HeLa-Kyoto cells, is diffusely distributed throughout
the cell. (B) GFP-labelled HIV-1 Gag is focally enriched at the plasma membrane. mCherry was used as control. (C) Upon co-expression, mCherry
labelled CANTDcb1 colocalizes with GFP-labelled HIV-1 Gag structures enriched at the plasma membrane. Scale bars, 10 mm.
doi:10.1371/journal.pone.0050026.g002
Figure 3. Detection of untagged HIV-1 Gag. (A) Subcellular distribution of eGFP-labelled CANTDcb1, expressed in HeLa-Kyoto cells. (B) Upon co-
expression with untagged HIV-1 Gag, eGFP-labelled CANTDcb1 specifically localizes at focal structures enriched at the plasma membrane. Scale bars,
10 mm.
doi:10.1371/journal.pone.0050026.g003
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detecting discrete, individual HIV assembly sites at the plasma
membrane (Figure 4 e).
Live cell analysis of HIV assembly
HIV-1 Gag assembly in living cells is described as a rapid
transition from a soluble, diffusely distributed form in the
cytoplasm to a focal and multimeric form that predominantly
localizes at the plasma membrane [12,13]. To test, whether it is
possible to resolve this dynamic event using CANTDcb1 for
detection, HeLa-Kyoto cells were co-transfected with pcHIV and
CANTDcb1eGFP and subjected to live cell confocal spinning disk
microscopy. Indeed, the overall distribution of CANTDcb1eGFP
signal rapidly changed from diffuse to focal, indicating HIV
assembly (Figure 5). Figure 5 shows the projections of 12 z-
sections recorded at each time point. Single confocal sections of
this time series clearly indicate that assembly processes occur
predominantly at the plasma membrane (Movie S1), consistent
with previous reports [12,23]. The shift to a predominant
cytoplasmic distribution of CANTDcb1 at the first time point in
Figure 3 indicated binding to HIV-1 Gag. To measure the
subcellular mobility of CANTDcb1 and discriminate between
different antigen-dependent organizational states, we performed
Fluorescence Recovery After Photobleaching (FRAP) experiments.
As expected, CANTDcb1 alone recovered rapidly (Figure 6a, b).
Upon co-expression with HIV-1 Gag, cytoplasmic, diffusely
distributed CANTDcb1 was still mobile, but recovered significantly
more slowly than the chromobody alone, indicating specific
antigen recognition in the cytoplasm (Figure 6a, b, c). In
contrast, FRAP analysis of focal structures at the plasma
membrane showed almost no fluorescence recovery, suggesting
specific and practically irreversible incorporation of CANTDcb1
into viral assemblies (Figure 6a, b, c).
Figure 4. Super-resolution microscopy with 3D-SIM. (A, B, C) Widefield vs. 3D-SIM imaging. (A) For comparison, the raw widefield image of a
HeLa-Kyoto cell, expressing CANTDcb1eGFP and unlabelled HIV-1 Gag is shown. Zoom regions show higher-detail illustration of a membranous
region. The bottom image shows a mid cross section in z and x dimension. (B, C) The same cell shown in (A), imaged using structured illumination.
Shown are confocal mid sections displayed in grayscale (B, eGFP) or false colors (C, eGFP, DAPI). Scale bar, 10 mm. (D) Shown are 3D-rendered images
of the cell shown in b–c, illustrating ubiquitous distribution of viral foci at the plasma membrane. (E). Intensity plot profiles over two representative
CANTDcb1-stained foci show distinct peaks in a 130–160 nanometer size range. Scale bar, 1 mm.
doi:10.1371/journal.pone.0050026.g004
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CANTDcb1 allows automated realtime high content
analysis of HIV-1 morphogenesis
Modern cell-based imaging techniques aim at automated image
analysis to extract a maximum of information from cellular assays.
However, such High-Content Analysis (HCA) crucially relies on
robust detection reagents. To test the application of CANTDcb1 in
HCA, we generated a HeLa-Kyoto cell line, stably expressing
CANTDcb1eGFP. These cells were then transfected with pcHIV
and subjected to automated time-lapse imaging for a period of
18 hours after transfection. About 6–9 hours after transfection,
chromobody distribution changed from ubiquitous to cytoplasmic
localization. Subsequently, the distribution pattern changed from
diffuse to focal structures accumulating at the membrane
(Figure 7a). We found that this diffuse versus focal pattern is
well suited for quantitative automated image analysis allowing the
objective quantification of assembly processes in large cell
numbers. For this purpose, the cytoplasmic fluorescence was used
to define cellular boundaries within which granules were identified
by intensity threshold segmentation and quantitatively monitored
over time (Figure 7b), demonstrating the usefulness of nanobody-
based, dynamic HIV detection in high content imaging.
Discussion
Here, we describe a new biosensor that allows detection and
dynamic tracing of HIV in living cells. This chromobody
(CANTDcb1) specifically recognizes the HIV-1 CA protein domain
and detects individual assembly sites as shown with super-
resolution microscopy. Live cell analysis demonstrated direct and
dynamic visualization of HIV assembly processes by CANTDcb1
and FRAP kinetic analysis revealed different mobility states, likely
corresponding to different organizational states of HIV-1 Gag
molecules during virion morphogenesis.
The development of Highly Active Antiretroviral Therapies
(HAART), targeting the HIV-1 replication cycle at various stages
has successfully constrained the pandemic AIDS progression
during the last years and decades. Nonetheless, it is known that
HIV-1 strains acquire multi-drug resistances, creating a constant
need for novel inhibitory compounds. Virion assembly processes,
visualized by CANTDcb1, appear well suited for automated image
analysis in HCA assay systems and thus provide a read-out for
targeted antiviral compound screens. Furthermore, the chromo-
body-based detection described here should be a versatile tool to
directly compare different HIV-1 variants, including primary
isolates and viruses carrying mutations in functional sites.
In HIV cell biology, recent analyses of the dynamics of HIV-1
biogenesis have provided new insights into the regulation of HIV-1
Gag trafficking, interaction with cellular co-factors and formation
of single virions [4,12,13,14]. Structural analyses have revealed the
intermolecular connectivity interfaces that coordinate the assembly
process of the mature HIV capsid at atomic resolution
[24,25,26,27,28,29]. Very recently, a cryo-electron microscopy
study revealed the molecular organization of the retroviral capsid
in the immature state at subnanometer resolution [30], demon-
strating remarkable, structural flexibility within the capsid.
However, little is known about the dynamic contributions of the
N- and C-terminal CA subdomains during assembly. We found
that CANTDcb1 specifically binds to the N-terminal domain of the
HIV-1 CA protein, which is involved in Gag-Gag interactions
during virion assembly. We did not observe any obvious defects
but cannot entirely exclude interference with virion morphogen-
esis caused by the CANTDcb1 chromobody. The dynamics,
structural flexibility and robustness of capsid assembly are
important topics of HIV biology. Generation of additional
chromobodies with different binding sites should enable kinetic
and functional studies to specifically probe the HIV assembly
process.
Materials and Methods
VHH Libraries and Screening
Alpaca immunizations with purified HIV-1 CA protein, VHH-
library construction and selection of CA-binding nanobodies were
carried out as described previously [17] and have been approved
by the government of Upper Bavaria (Permit number: 55.2-1-54-
2531.6-9-06). In brief, 6 weeks after immunization, ,100 ml
blood were collected and lymphocytes were isolated by Ficoll
gradient centrifugation. Total RNA was extracted and mRNA was
reverse transcribed to cDNA. Next, the VHH repertoire was
isolated in 3 subsequent PCR reactions. First, primers CALL001
(59-GTC CTG GCT GCT CTT CTA CA A GG-39) and
CALL002 (59-GGT ACG TGC TGT TGA ACT GTT CC-39)
Figure 5. Visualizing the formation of HIV-1. A HeLa-Kyoto cell, expressing CANTDcb1eGFP and HIV-1 Gag was monitored for 90 min at 1 min
time intervals using confocal spinning disk microscopy (see also Movie S1). Shown are projections of 12 z-sections per time point. Scale bar, 10 mm.
doi:10.1371/journal.pone.0050026.g005
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Figure 6. FRAP analysis of subcellular chromobody populations. (A) Fluorescence recovery of CANTDcb1eGFP over time, either expressed
alone (upper panel) or in combination with HIV-1 Gag (lower panel). Arrows in the lower panel indicate two regions of interest: Diffusely distributed
CANTDcb1eGFP signal in the cytoplasm and focal structures at the outer cellular rim, indicating virion assembly sites at the membrane. Scale bar,
10 mm. (B) Quantitative FRAP analysis reveals different mobility states of unbound and ubiquitous, diffusely and cytoplasmic as well as focal and
membranous CANTDcb1eGFP signal. Errors are standard 0deviations (n$7). (C) 3D-FRAP representation of the same cell shown in (A) (lower panel),
illustrating cytoplasmic recovery to almost initial level, while cumulated, membranous signal shows no recovery.
doi:10.1371/journal.pone.0050026.g006
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were used to isolate and separate heavy chain sequences that miss
the CH1 exon (hcAb-specific) from CH1-bearing sequences
(conventional heavy chains). Next, VHH genes were amplified
with two subsequent nested PCRs with Forward primers SM017
and SM018 (59-CCA GCC GGC CAT GGC TCA GGT GCA
GCT GGT GGA GTC TGG-39and 59-CCA GCC GGC CAT
GGC TGA TGT GCA GCT GGT GGA GTC TGG-39,
respectively) and Reverse primer CALL002 (1. Nested PCR), as
well as Forward primer A4short (59-CAT GCC ATG ACT CGC
GGC CAC GCC GGC CAT GGC-39) and Reverse Primer 38
(59-GGA CTA GTG CGG CCG CTG GAG ACG GTG ACC
TGG GT-39; 2. Nested PCR). The VHH library was then
subcloned into pHen4 phagemid vector to create surface-displayed
VHH fusion proteins with the phage protein pIII. The phage
library was then bio-panned for CA-specific binders in 3
subsequent panning rounds, followed by antigen recognition
testing (phage-ELISA) of individual clones.
Plasmids and Proteins
For bacterial expression of nanobodies, sequences were cloned
into the pHen6 vector, thereby adding a C-terminal 66His-tag for
IMAC purification as described previously [31]. The expression
plasmid for CA has been described previously [32,33]. Additional
CA variants (N-terminal CA domain [CANTD; residues 1–146], C-
terminal CA domain [CACTD; 146–231]) were obtained by PCR
cloning from pET11c-CA and confirmed by sequence analysis.
For protein production, E. coli BL21(DE3) CodonPlus-RIL
(Stratagene) was used. Expression and purification CANTDnb1 was
carried out as described previously [31]. Full-length CA was
purified as described [32,33,34]. For functional characterization in
mammalian cells, translational fusions of CANTDcb1 with
mCherry and eGFP were constructed. The corresponding VHH
genes were PCR-amplified with Primers
VHH F (59-GGGGAGATCTCCATGGCGATCGCG-
CAGGTGCAGCTG-39) and VHH R (59-
CCGGGCGGCCGCTGGAGACGGTGACCTGGGT-39) con-
taining AsiSI and NotI restriction sites, respectively, digested with
AsiSI and NotI and ligated into pEGFP-N1 and a modified
pEYFP-N1 vector (Clontech, CA, USA), where the YFP sequence
had been replaced by the mCherry coding region. Intracellular
Gag localization and interaction with CANTDcb1 was determined
using non-infectious HIV-1 plasmids either untagged (pcHIV) or
as a 1:1 co-transfection with a plasmid encoding eGFP embedded
within the MA domain of gag (pcHIV.eGFP) [7,8].
Figure 7. Automated monitoring of HIV morphogenesis. (A) HeLa-Kyoto cells, stably expressing CANTDcb1eGFP were transfected with pcHIV,
encoding untagged Gag and monitored by time lapse epifluorescence microscopy for 18 h at 10 min time intervals. Scale bar, 50 mm. (B) Automated
pattern recognition for High Content Analysis. eGFP fluorescence was used to determine borders of individual cells by intensity threshold
segmentation, indicated by green lines. Particles within cells were segmented and defined by size and intensity threshold setting, indicated by cyan
coloured lines. Scale bars, 50 mm. The average number of granules per cell was determined and plotted over time. Error bars represent the standard
error of the mean (n,400 cells).
doi:10.1371/journal.pone.0050026.g007
Live-Cell Detection of HIV-1 with Chromobodies
PLOS ONE | www.plosone.org 7 November 2012 | Volume 7 | Issue 11 | e50026
QCM Affinity Measurements
Quartz Crystal Microbalance measurements were performed on
an Attana A100 instrument. The ligand (purified CANTDnb1) was
covalently immobilized on a Carboxyl surface via NHS esterifi-
cation according to the manufacturers’ instructions. Purified full-
length CA protein was run over the surface in decreasing
concentrations (10, 5, 2.5, 1.25, 0.6125 mg/ml; triplicate injec-
tions). Contact time for association was set to 80 seconds.
Dissociation was recorded for 220 seconds. Data fitting and rate
constant calculation was carried out with ClampXP software.
Cells
HeLa-Kyoto cells (a HeLa cell line characterized by little cell
motility and thus high suitability for time lapse imaging) were
maintained in DMEM supplemented with 10% fetal calf serum
and gentamycin at 50 mg/ml (PAA, Germany). Transfection was
performed using polyethylenimine (PEI; Sigma, Germany). To
generate DNA/PEI complexes for transfection in 6-well plates,
2 mg DNA were mixed with 6 mg PEI in 150 ml DMEM per well,
incubated for 15 minutes and added to the cells. For Confocal
Microscopy 106 cells were seeded on gridded 18618 mm
coverslips in a 6-well plate format. For cotransfection, 1:1:1
plasmid mixtures of pcHIV.eGFP/pcHIV and mCherry (negative
control) or CANTDcb1mCherry were prepared. For visualization
of untagged HIV-1 Gag, a 1:1 mixture of pcHIV and
CANTDcb1eGFP plasmid was prepared. 18 hours post transfec-
tion, cells were washed, fixed with 3,7% formaldehyde/PBS,
permeabilized with 0,5% Triton X-100/PBS, DAPI (Invitrogen,
USA) stained and mounted in Vectashield anti-fading reagent
(Vector Laboratories, USA) on object slides. For 3D-SIM, HeLa-
Kyoto cells were co-transfected with pcHIV and CANTDcb1eGFP.
3D-SIM requires extensive laser excitation, easily causing fluor-
ophore bleaching. For eGFP signal stabilization, cells were
therefore stained with GFP-booster (ChromoTek, Germany)
according to the manufacturer’s protocol. HeLa-Kyoto cells,
stably expressing CANTDcb1eGFP were generated by stable
transfection, followed by single cell sorting, clonal cultivation
and tested by Western Blot analysis with a monoclonal a-GFP
antibody (Roche, Switzerland). Stable cell lines were maintained in
DMEM supplemented with 10% fetal calf serum, gentamycine at
50 mg/ml (PAA, Germany) and G418 at 1 mg/ml (PAA,
Germany). For live cell analysis, 104 cells were seeded in ibidi m-
slides (Ibidi, Germany). During acquisition, cells were maintained
in phenol red-free, HEPES buffered DMEM (PAA, Germany).
Confocal Microscopy
Colocalization analysis with fixed cells was performed with a
confocal laser scanning microscope (TCS SP5/AOBS; Leica),
using a UV-transmitting HCX PL 636/1.4 oil objective.
Fluorophores were excited with a 405 nm diode laser (49,6-
diamidino-2-phenylindole) 488-nm Ar laser line (eGFP) and a 561-
nm diode pumped solid state laser line (mCherry). Images were
recorded with a frame size of 5126512 pixels, a pixel size of
50 nm and the pinhole opened to 1 Airy unit.
3D-Structured Illumination Microscopy
3D-SIM was performed with an DeltaVision OMX v3 (Applied
Precision) equipped with 405, 488 and 593 nm laser diodes, a
1006/1.4 NA Plan-Apochromat oil objective lens (Olympus) and
Cascade II:512 EM CCD cameras (Photometrics). Samples were
illuminated by directing coherence-scrambled laser light through a
movable optical grating, generating a fine-striped illumination
pattern on each plane. By moving the stage in z direction (125 nm
steps), 15 images per z-section (five phases, three angles) were
acquired and computationally processed to obtain a 3D dataset
with a twofold enhanced optical resolution compared with
conventional light microscopy [21,22].
Live Cell Confocal Microscopy
Live cell imaging of individual cells was performed on an
UltraVIEW VoX spinning disc microscope (PerkinElmer) assem-
bled to an Axio Observer D1 stand (Carl Zeiss, Inc.), equipped
with a 636/1.4 NA Plan-Apochromat oil immersion objective and
a heated environmental chamber set to 37uC and CO2 perfusion
set to 5%. Fluorophores were excited with the 488 nm laser line.
Individual cells were recorded 8 hours post transfection for 1.5–
2.5 h at 1 min time intervals and 12 z-sections per time point,
covering 6 mm in z direction (500 nm steps). Z-stack projections
were performed using Volocity software. For FRAP analysis,
typically one third of the cell (covering membranous and
cytoplasmic regions) was photobleached using two iterations of
the Argon laser line set to 100% transmission. 24 prebleach frames
(12 frames/min) and 84 postbleach frames (initial speed of 12
frames/min for the first 12 frames, followed by intervals of 6
frames/min) were recorded. Quantitative analysis was performed
with ImageJ. Fluorescence recovery in membranous and cytoplas-
mic regions of interest was measured as the percentage of
postbleach intensity compared to prebleach intensity. At least 7
cells were evaluated and the corresponding standard deviations
were determined.
Live Cell Widefield Microscopy and High-Content
Analysis
Long-term visualization of HIV-1 Gag assembly in living cells
was analyzed using an InCell Analyzer 1000 (GE Healthcare)
equipped with a 206/0.45 Plan-Fluor air objective. Images of
living cells, seeded in Ibidi m-slides, were automatically acquired
from 12 different positions with exposure times of 500 ms for
eGFP fusion proteins using standard filter HQ480/40. Quantita-
tive image analysis was performed using INCell Developer
Toolbox 1.7. Cells were segmented and individually identified
by setting an intensity-based threshold. Next, the average number
of granule-like structures per GFP positive cell was determined by
size- and intensity-based threshold segmentation. Data were
statistically evaluated, and visualized using Microsoft Excel.
Supporting Information
Movie S1 Visualizing the formation of HIV-1. The time
series corresponds to Figure 5. Shown is a HeLa-Kyoto cell,
expressing CANTDcb1eGFP and HIV-1 Gag, monitored for
90 min at 1 min time intervals. On the left, a projection of 12 z-
sections is shown. On the right, a confocal mid section is shown.
(AVI)
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